文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

肺复张与滴定呼气末正压对急性呼吸窘迫综合征患者死亡率的影响:一项随机临床试验

Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01
一句话结论中重度ARDS患者采用肺复张联合滴定PEEP策略,28天全因死亡率55.3% vs 低PEEP组49.3%(HR 1.20),不支持常规使用。

这项多中心随机试验在9个国家120个ICU纳入1010例中重度ARDS成人患者,比较肺复张联合最佳呼吸系统顺应性滴定PEEP策略(n=501)与低PEEP策略(n=509)。主要终点28天全因死亡率在实验组为55.3%,对照组为49.3%(HR 1.20;95%CI 1.01-1.42;P=.041)。实验组6个月死亡率更高(65.3% vs 59.9%;HR 1.18;95%CI 1.01-1.38;P=.04),无呼吸机天数更少(5.3 vs 6.4天;差值-1.1;95%CI -2.1至-0.1;P=.03),需引流的张力性气胸(3.2% vs 1.2%;差值2.0%;95%CI 0.0%-4.0%;P=.03)和气压伤(5.6% vs 1.6%;差值4.0%;95%CI 1.5%-6.5%;P=.001)风险更高。ICU住院时间、住院时间、ICU死亡率和院内死亡率无显著差异。结论不支持在该人群中常规使用肺复张联合滴定PEEP。

要点

  • 中重度ARDS患者28天全因死亡率:肺复张+滴定PEEP组55.3% vs 低PEEP组49.3%(HR 1.20;95%CI 1.01-1.42;P=.041)。
  • 6个月死亡率:实验组65.3% vs 对照组59.9%(HR 1.18;95%CI 1.01-1.38;P=.04)。
  • 实验组无呼吸机天数更少:5.3 vs 6.4天(差值-1.1;95%CI -2.1至-0.1;P=.03)。
  • 实验组需引流的气胸风险更高:3.2% vs 1.2%(差值2.0%;95%CI 0.0%-4.0%;P=.03)。
  • 实验组气压伤风险更高:5.6% vs 1.6%(差值4.0%;95%CI 1.5%-6.5%;P=.001)。

适用人群与场景

  • 成人中重度急性呼吸窘迫综合征(ARDS)患者,来自9个国家120个ICU。
  • 所有患者接受容量辅助控制通气模式直至撤机。

处置流程与药物剂量

  • 实验组:采用肺复张操作联合根据最佳呼吸系统顺应性滴定PEEP的策略(n=501)。
  • 对照组:采用低PEEP策略(n=509)。
  • 所有患者均接受容量辅助控制模式通气直至撤机。

研究设计与关键结果

  • 多中心随机试验,纳入1010例成人中重度ARDS患者(37.5%女性;平均年龄50.9岁,SD 17.4),实验组501例、对照组509例。
  • 28天全因死亡率:实验组55.3%(277/501) vs 对照组49.3%(251/509),HR 1.20(95%CI 1.01-1.42;P=.041)。
  • 6个月死亡率:实验组65.3% vs 对照组59.9%,HR 1.18(95%CI 1.01-1.38;P=.04)。
  • 无呼吸机天数(至第28天):实验组平均5.3天 vs 对照组6.4天,差值-1.1(95%CI -2.1至-0.1;P=.03)。
  • 7天内需引流的气胸:实验组3.2% vs 对照组1.2%,差值2.0%(95%CI 0.0%-4.0%;P=.03)。
  • 7天内气压伤:实验组5.6% vs 对照组1.6%,差值4.0%(95%CI 1.5%-6.5%;P=.001)。
  • ICU住院时间、住院时间、ICU死亡率及院内死亡率两组间无显著差异。

证据类型、等级与局限

  • 证据类型:多中心随机临床试验(RCT),注册号NCT01374022。
  • 作者结论:中重度ARDS患者中,肺复张联合滴定PEEP策略相比低PEEP策略增加28天全因死亡率,这些发现不支持在该人群中常规使用肺复张操作和PEEP滴定。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 中重度ARDS成人患者中,肺复张联合最佳顺应性滴定PEEP策略相比低PEEP策略增加28天全因死亡率(55.3% vs 49.3%),并增加6个月死亡率、减少无呼吸机天数、增加需引流气胸和气压伤风险。
  • 作者结论指出这些发现不支持在中重度ARDS患者中常规使用肺复张操作和PEEP滴定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The effects of recruitment maneuvers and positive end-expiratory pressure (PEEP) titration on clinical outcomes in patients with acute respiratory distress syndrome (ARDS) remain uncertain.

OBJECTIVE: To determine if lung recruitment associated with PEEP titration according to the best respiratory-system compliance decreases 28-day mortality of patients with moderate to severe ARDS compared with a conventional low-PEEP strategy.

DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized trial conducted at 120 intensive care units (ICUs) from 9 countries from November 17, 2011, through April 25, 2017, enrolling adults with moderate to severe ARDS.

INTERVENTIONS: An experimental strategy with a lung recruitment maneuver and PEEP titration according to the best respiratory-system compliance (n = 501; experimental group) or a control strategy of low PEEP (n = 509). All patients received volume-assist control mode until weaning.

MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality until 28 days. Secondary outcomes were length of ICU and hospital stay; ventilator-free days through day 28; pneumothorax requiring drainage within 7 days; barotrauma within 7 days; and ICU, in-hospital, and 6-month mortality.

RESULTS: A total of 1010 patients (37.5% female; mean [SD] age, 50.9 [17.4] years) were enrolled and followed up. At 28 days, 277 of 501 patients (55.3%) in the experimental group and 251 of 509 patients (49.3%) in the control group had died (hazard ratio [HR], 1.20; 95% CI, 1.01 to 1.42; P = .041). Compared with the control group, the experimental group strategy increased 6-month mortality (65.3% vs 59.9%; HR, 1.18; 95% CI, 1.01 to 1.38; P = .04), decreased the number of mean ventilator-free days (5.3 vs 6.4; difference, -1.1; 95% CI, -2.1 to -0.1; P = .03), increased the risk of pneumothorax requiring drainage (3.2% vs 1.2%; difference, 2.0%; 95% CI, 0.0% to 4.0%; P = .03), and the risk of barotrauma (5.6% vs 1.6%; difference, 4.0%; 95% CI, 1.5% to 6.5%; P = .001). There were no significant differences in the length of ICU stay, length of hospital stay, ICU mortality, and in-hospital mortality.

CONCLUSIONS AND RELEVANCE: In patients with moderate to severe ARDS, a strategy with lung recruitment and titrated PEEP compared with low PEEP increased 28-day all-cause mortality. These findings do not support the routine use of lung recruitment maneuver and PEEP titration in these patients.

TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01374022.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Cavalcanti AB, Suzumura ÉA, Laranjeira LN, et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2017. PMID: 28973363. doi:10.1001/jama.2017.14171

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。